Catalyst Wire Dossier Catalyst Wire Dossier

D-MNA

· SkinJect, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for D-MNA, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma [Phase 2]

See pricing